FDA Finalizing Study Protocols For DTC Ad Brief Summary Research
This article was originally published in The Pink Sheet Daily
Executive Summary
In the first of three studies, FDA will examine consumer responses to a mock weight-loss drug ad to determine how and why consumers use the brief summary. Research data will be collected in the spring, but a final guidance on the brief summary content and format “will be awhile,” FDA says.